Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.06% vs 18.97% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 131.58% vs 79.35% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 30.26% vs 7,500.00% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -1.35% vs 1.37% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Xeris Biopharma Holdings, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 4.06% vs 18.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 37.02% vs 12.42% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 131.58% vs 79.35% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 103.82% vs -28.69% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 30.26% vs 7,500.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 201.02% vs -512.50% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -1.35% vs 1.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -6.41% vs 14.71% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






